An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

Drugs that target wakefulness, molecules in cannabis and wearable devices that modulate brain activity could help people with ...

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...

While sparking excitement among biopharma companies focused on rare and ultrarare indications, experts say FDA Commissioner ...

The new bill extends previous legislation, codifying how clinics can provide access to drugs that have only been through ...

Spanning four continents and enrolling hundreds of people, a new clinical trial will ... pirfenidone—approved for treating arthritis and lung disease, respectively—can be repurposed to reduce or ...

As results of the long-term trial are pending, AbbVie, the maker of tavapadon, will soon file an application to the Food and Drug Administration for approval of the drug. “Of course, this is a ...

Other than supportive care, PMM2-CDG has no drug ... approval in this indication. In PMM2, the Applied small molecule has been tested in a single patient in an investigator-initiated clinical ...

One in six participants in phase 2 cancer trials ... a drug that eventually gains FDA approval. Conversely, therapies that advance to phase 3 have already demonstrated the potential of clinical ...

One in 6 patients in phase 2 cancer trials ... were FDA approval alone, FDA approval plus NCCN off-label recommendations, and FDA approval for drugs considered to have a substantial clinical ...